Sign in
4

Changes in Ownership

Adicet Bio, Inc. Filed Acc 0001209191-23-046095

Options or other derivatives

  • Director acquired 81,900 shares (grant or award)
  • Director returned 81,900 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kauffman Michael Director 2023-08-14 Returned to the company · Stock Option (Right to Buy) −37,000 0 D: show line 1 in the form
Kauffman Michael Director 2023-08-14 Grant or award · Stock Option (Right to Buy) +37,000 37,000 D: show line 2 in the form
Kauffman Michael Director 2023-08-14 Returned to the company · Stock Option (Right to Buy) −18,500 0 D: show line 3 in the form
Kauffman Michael Director 2023-08-14 Grant or award · Stock Option (Right to Buy) +18,500 18,500 D: show line 4 in the form
Kauffman Michael Director 2023-08-14 Returned to the company · Stock Option (Right to Buy) −26,400 0 D: show line 5 in the form
Kauffman Michael Director 2023-08-14 Grant or award · Stock Option (Right to Buy) +26,400 26,400 D: show line 6 in the form
Loading xslF345X05/doc4.xml…